June 22 (Reuters) - Medexus Pharmaceuticals Inc MDP.TO :
* SEES Q4 REVENUE UP 15 PERCENT
* DELIVERED TOTAL REVENUE OF $20.3 MILLION IN FISCAL Q4
2022, AN
INCREASE OF 15% COMPARED TO FISCAL Q4 2021
* CASH AND CASH EQUIVALENTS OF $10.0 MILLION (WITH $11.2
MILLION
OF TOTAL AVAILABLE LIQUIDITY) AT END OF FISCAL Q4 2022
* NET LOSS WAS $5.3 MILLION FOR FISCAL Q4 2022
* Q4 REVENUE VIEW $18.5 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5F47fH
Further company coverage: MDP.TO
((Reuters.Briefs@thomsonreuters.com;))